{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:51:36Z","timestamp":1648810296770},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00117-013-2576-4","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T11:21:29Z","timestamp":1393586489000},"page":"233-240","source":"Crossref","is-referenced-by-count":1,"title":["Therapiemonitoring im MRT unter neoadjuvanter Therapie"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"Grandl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ingrisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hellerhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,2]]},"reference":[{"key":"2576_CR1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.mri.2013.07.002","volume":"31","author":"Abramson","year":"2013","unstructured":"Abramson RG, Li X, Hoyt TL et al (2013) Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results. Magn Reson Imaging 31:1457\u20131464","journal-title":"Magn Reson Imaging"},{"key":"2576_CR2","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-07-4310","volume":"14","author":"Ah-See","year":"2008","unstructured":"Ah-See ML, Makris A, Taylor NJ et al (2008) Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 14:6580\u20136589","journal-title":"Clin Cancer Res"},{"key":"2576_CR3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1075-122X.2006.00220.x","volume":"12","author":"Akazawa","year":"2006","unstructured":"Akazawa K, Tamaki Y, Taguchi T et al (2006) Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J 12:130\u2013137","journal-title":"Breast J"},{"key":"2576_CR4","doi-asserted-by":"crossref","unstructured":"Arlinghaus LR, Li X, Levy M et al (2010) Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol. doi:10.1155\/2010\/919620","DOI":"10.1155\/2010\/919620"},{"key":"2576_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1014856713942","volume":"72","author":"Balu-Maestro","year":"2002","unstructured":"Balu-Maestro C, Chapellier C, Bleuse A et al (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72:145\u2013152","journal-title":"Breast Cancer Res Treat"},{"key":"2576_CR6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.11490","volume":"98","author":"Bedrosian","year":"2003","unstructured":"Bedrosian I, Mick R, Orel SG et al (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98:468\u2013473","journal-title":"Cancer"},{"key":"2576_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjc.6604171","volume":"98","author":"Bhattacharyya","year":"2008","unstructured":"Bhattacharyya M, Ryan D, Carpenter R et al (2008) Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Br J Cancer 98:289\u2013293","journal-title":"Br J Cancer"},{"key":"2576_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archsurg.142.5.441","volume":"142","author":"Bilimoria","year":"2007","unstructured":"Bilimoria KY, Cambic A, Hansen NM et al (2007) Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg 142:441\u2013445 (discussion 445\u2013447)","journal-title":"Arch Surg"},{"key":"2576_CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.197.3.7480749","volume":"197","author":"Boetes","year":"1995","unstructured":"Boetes C, Mus RD, Holland R et al (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743\u2013747","journal-title":"Radiology"},{"key":"2576_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/radiol.2532081718","volume":"253","author":"Bogner","year":"2009","unstructured":"Bogner W, Gruber S, Pinker K et al (2009) Diffusion-weighted MR for differentiation of breast lesions at 3.0\u00a0T: how does selection of diffusion protocols affect diagnosis? Radiology 253:341\u2013351","journal-title":"Radiology"},{"key":"2576_CR11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.11110814","volume":"261","author":"Chen","year":"2011","unstructured":"Chen JH, Bahri S, Mehta RS et al (2011) Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology 261:735\u2013743","journal-title":"Radiology"},{"key":"2576_CR12","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","volume":"119","author":"De","year":"2013","unstructured":"De Los Santos JF, Cantor A, Amos KD et al (2013) Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. Cancer 119:1776\u20131783","journal-title":"Cancer"},{"key":"2576_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.breast.2007.02.004","volume":"16","author":"Del","year":"2007","unstructured":"Del Frate C, Borghese L, Cedolini C et al (2007) Role of pre-surgical breast MRI in the management of invasive breast carcinoma. Breast 16:469\u2013481","journal-title":"Breast"},{"key":"2576_CR14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00330-005-0043-y","volume":"16","author":"Deurloo","year":"2006","unstructured":"Deurloo EE, Klein Zeggelink WF, Teertstra HJ et al (2006) Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 16:692\u2013701","journal-title":"Eur Radiol"},{"key":"2576_CR15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483\u20132493","journal-title":"J Clin Oncol"},{"key":"2576_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"Fisher","year":"2002","unstructured":"Fisher ER, Wang J, Bryant J et al (2002) Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95:681\u2013695","journal-title":"Cancer"},{"key":"2576_CR17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.12110748","volume":"263","author":"Hylton","year":"2012","unstructured":"Hylton NM, Blume JD, Bernreuter WK et al (2012) Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy \u2013 results from ACRIN 6657\/I-SPY TRIAL. Radiology 263:663\u2013672","journal-title":"Radiology"},{"key":"2576_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00330-009-1550-z","volume":"20","author":"Iacconi","year":"2010","unstructured":"Iacconi C, Giannelli M, Marini C et al (2010) The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 20:303\u2013308","journal-title":"Eur Radiol"},{"key":"2576_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10928-013-9315-3","volume":"40","author":"Ingrisch","year":"2013","unstructured":"Ingrisch M, Sourbron S (2013) Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer. J Pharmacokinet Pharmacodyn 40:281\u2013300","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2576_CR20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmri.22726","volume":"34","author":"Jensen","year":"2011","unstructured":"Jensen LR, Garzon B, Heldahl MG et al (2011) Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging 34:1099\u20131109","journal-title":"J Magn Reson Imaging"},{"key":"2576_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.2007.11.5352","volume":"26","author":"Jeruss","year":"2008","unstructured":"Jeruss JS, Mittendorf EA, Tucker SL et al (2008) Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26:246\u2013252","journal-title":"J Clin Oncol"},{"key":"2576_CR22","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","volume":"18","author":"Kaufmann","year":"2007","unstructured":"Kaufmann M, Von Minckwitz G, Bear HD et al (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18:1927\u20131934","journal-title":"Ann Oncol"},{"key":"2576_CR23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1148\/radiol.2443051661","volume":"244","author":"Kuhl","year":"2007","unstructured":"Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244:672\u2013691","journal-title":"Radiology"},{"key":"2576_CR24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiol.2263020041","volume":"226","author":"Lee","year":"2003","unstructured":"Lee SG, Orel SG, Woo IJ et al (2003) MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226:773\u2013778","journal-title":"Radiology"},{"key":"2576_CR25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa065447","volume":"356","author":"Lehman","year":"2007","unstructured":"Lehman CD, Gatsonis C, Kuhl CK et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295\u20131303","journal-title":"N Engl J Med"},{"key":"2576_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jncimonographs\/lgr031","volume":"2011","author":"Li","year":"2011","unstructured":"Li SP, Padhani AR, Makris A (2011) Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment. J Natl Cancer Inst Monogr 2011:103\u2013107","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2576_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12032-011-9842-y","volume":"29","author":"Li","year":"2012","unstructured":"Li XR, Cheng LQ, Liu M et al (2012) DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol 29:425\u2013431","journal-title":"Med Oncol"},{"key":"2576_CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2214\/ajr.180.2.1800333","volume":"180","author":"Liberman","year":"2003","unstructured":"Liberman L, Morris EA, Kim CM et al (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180:333\u2013341","journal-title":"AJR Am J Roentgenol"},{"key":"2576_CR29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1245\/s10434-006-9011-2","volume":"13","author":"Loibl","year":"2006","unstructured":"Loibl S, Von Minckwitz G, Raab G et al (2006) Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial. Ann Surg Oncol 13:1434\u20131442","journal-title":"Ann Surg Oncol"},{"key":"2576_CR30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00330-004-2246-z","volume":"14","author":"Londero","year":"2004","unstructured":"Londero V, Bazzocchi M, Del Frate C et al (2004) Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14:1371\u20131379","journal-title":"Eur Radiol"},{"key":"2576_CR31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K et al (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307\u20131318","journal-title":"Eur Radiol"},{"key":"2576_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jncimonographs\/lgr027","volume":"2011","author":"Mehta","year":"2011","unstructured":"Mehta S, Hughes NP, Buffa FM et al (2011) Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. J Natl Cancer Inst Monogr 2011:71\u201374","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2576_CR33","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1245\/s10434-013-3038-y","volume":"20","author":"Mukhtar","year":"2013","unstructured":"Mukhtar RA, Yau C, Rosen M et al (2013) Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007\/150012; ACRIN 6657). Ann Surg Oncol 20:3823\u20133830","journal-title":"Ann Surg Oncol"},{"key":"2576_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2214\/ajr.169.2.9242745","volume":"169","author":"Mumtaz","year":"1997","unstructured":"Mumtaz H, Hall-Craggs MA, Davidson T et al (1997) Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169:417\u2013424","journal-title":"AJR Am J Roentgenol"},{"key":"2576_CR35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/02841861003610184","volume":"49","author":"Nilsen","year":"2010","unstructured":"Nilsen L, Fangberget A, Geier O et al (2010) Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 49:354\u2013360","journal-title":"Acta Oncol"},{"key":"2576_CR36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjc.6603515","volume":"96","author":"O","year":"2007","unstructured":"O\u2019Connor JP, Jackson A, Parker GJ et al (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96:189\u2013195","journal-title":"Br J Cancer"},{"key":"2576_CR37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr2815","volume":"13","author":"O","year":"2011","unstructured":"O\u2019Flynn EA, Desouza NM (2011) Functional magnetic resonance: biomarkers of response in breast cancer. Breast Cancer Res 13:204","journal-title":"Breast Cancer Res"},{"key":"2576_CR38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1148\/radiol.2392021099","volume":"239","author":"Padhani","year":"2006","unstructured":"Padhani AR, Hayes C, Assersohn L et al (2006) Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 239:361\u2013374","journal-title":"Radiology"},{"key":"2576_CR39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1148\/radiol.10092021","volume":"257","author":"Park","year":"2010","unstructured":"Park SH, Moon WK, Cho N et al (2010) Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 257:56\u201363","journal-title":"Radiology"},{"key":"2576_CR40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jmri.22078","volume":"31","author":"Partridge","year":"2010","unstructured":"Partridge SC, Demartini WB, Kurland BF et al (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 31:562\u2013570","journal-title":"J Magn Reson Imaging"},{"key":"2576_CR41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1148\/radiol.2433060838","volume":"243","author":"Pediconi","year":"2007","unstructured":"Pediconi F, Catalano C, Roselli A et al (2007) Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243:670\u2013680","journal-title":"Radiology"},{"key":"2576_CR42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.mri.2005.11.005","volume":"24","author":"Pickles","year":"2006","unstructured":"Pickles MD, Gibbs P, Lowry M et al (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843\u2013847","journal-title":"Magn Reson Imaging"},{"key":"2576_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-004-5819-2","volume":"91","author":"Pickles","year":"2005","unstructured":"Pickles MD, Lowry M, Manton DJ et al (2005) Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91:1\u201310","journal-title":"Breast Cancer Res Treat"},{"key":"2576_CR44","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00330-012-2653-5","volume":"22","author":"Prevos","year":"2012","unstructured":"Prevos R, Smidt ML, Tjan-Heijnen VC et al (2012) Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review. Eur Radiol 22:2607\u20132616","journal-title":"Eur Radiol"},{"key":"2576_CR45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD et al (2008) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26:778\u2013785","journal-title":"J Clin Oncol"},{"key":"2576_CR46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2214\/ajr.181.5.1811275","volume":"181","author":"Rosen","year":"2003","unstructured":"Rosen EL, Blackwell KL, Baker JA et al (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275\u20131282","journal-title":"AJR Am J Roentgenol"},{"key":"2576_CR47","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"Sardanelli","year":"2010","unstructured":"Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296\u20131316","journal-title":"Eur J Cancer"},{"key":"2576_CR48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-008-0025-2","volume":"114","author":"Schegerin","year":"2009","unstructured":"Schegerin M, Tosteson AN, Kaufman PA et al (2009) Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective. Breast Cancer Res Treat 114:537\u2013547","journal-title":"Breast Cancer Res Treat"},{"key":"2576_CR49","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00117-010-2009-6","volume":"50","author":"Schlossbauer","year":"2010","unstructured":"Schlossbauer T, Reiser M, Hellerhoff K (2010) Wertigkeit von Mammographie, Sonographie und MRT zur Verlaufsbeurteilung der neoadjuvanten Chemotherapie bei lokal fortgeschrittenem Mammakarzinom. Radiologe 50:1008\u20131013","journal-title":"Radiologe"},{"key":"2576_CR50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/nbm.1245","volume":"22","author":"Sharma","year":"2009","unstructured":"Sharma U, Danishad KK, Seenu V et al (2009) Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 22:104\u2013113","journal-title":"NMR Biomed"},{"key":"2576_CR51","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.acra.2011.11.003","volume":"19","author":"Singer","year":"2012","unstructured":"Singer L, Wilmes LJ, Saritas EU et al (2012) High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol 19:526\u2013534","journal-title":"Acad Radiol"},{"key":"2576_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1524-4741.2002.08304.x","volume":"8","author":"Slanetz","year":"2002","unstructured":"Slanetz PJ, Edmister WB, Yeh ED et al (2002) Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8:145\u2013148","journal-title":"Breast J"},{"key":"2576_CR53","first-page":"3889","volume":"47","author":"Swain","year":"1987","unstructured":"Swain SM, Sorace RA, Bagley CS et al (1987) Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47:3889\u20133894","journal-title":"Cancer Res"},{"key":"2576_CR54","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414\u20134422","journal-title":"J Clin Oncol"},{"key":"2576_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/radiol.12111177","volume":"263","author":"Tateishi","year":"2012","unstructured":"Tateishi U, Miyake M, Nagaoka T et al (2012) Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET\/CT and dynamic contrast-enhanced MR imaging \u2013 prospective assessment. Radiology 263:53\u201363","journal-title":"Radiology"},{"key":"2576_CR56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/mdi001","volume":"16","author":"Von","year":"2005","unstructured":"Von Minckwitz G, Blohmer JU, Raab G et al (2005) In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol 16:56\u201363","journal-title":"Ann Oncol"},{"key":"2576_CR57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00117-005-1303-1","volume":"47","author":"Wasser","year":"2007","unstructured":"Wasser K, Klein SK, Junkermann H et al (2007) Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI? Radiologe 47:421\u2013429","journal-title":"Radiologe"},{"key":"2576_CR58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1200\/JCO.2005.03.4645","volume":"24","author":"Wedam","year":"2006","unstructured":"Wedam SB, Low JA, Yang SX et al (2006) Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol 24:769\u2013777","journal-title":"J Clin Oncol"},{"key":"2576_CR59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2463\/mrms.4.35","volume":"4","author":"Woodhams","year":"2005","unstructured":"Woodhams R, Matsunaga K, Kan S et al (2005) ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4:35\u201342","journal-title":"Magn Reson Med Sci"},{"key":"2576_CR60","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","volume":"184","author":"Yeh","year":"2005","unstructured":"Yeh E, Slanetz P, Kopans DB et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868\u2013877","journal-title":"AJR Am J Roentgenol"},{"key":"2576_CR61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmri.21060","volume":"26","author":"Yu","year":"2007","unstructured":"Yu HJ, Chen JH, Mehta RS et al (2007) MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging 26:615\u2013623","journal-title":"J Magn Reson Imaging"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-013-2576-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-013-2576-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-013-2576-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:04:39Z","timestamp":1565229879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-013-2576-4"}},"subtitle":["RECIST und funktionelle Bildgebung"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s00117-013-2576-4","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}